| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 10/08/2008 | EP1976828A1 Diamine derivatives as inhibitors of leukotriene a4 hydrolase |
| 10/08/2008 | CN101282954A Therapeutic agents |
| 10/08/2008 | CN101282953A Therapeutic agents |
| 10/08/2008 | CN101282933A Novel NK1 and NK2 antagonists |
| 10/08/2008 | CN101282932A Carboxyamine compounds and their use in the treatment of HDAC dependent diseases |
| 10/07/2008 | US7432392 Ester derivatives and medical use thereof |
| 10/07/2008 | US7432389 Inhibiting beta-secretase enzyme activity and A beta peptide production, to reduce amyloid beta deposits or plaques |
| 10/07/2008 | US7432377 of preparing 4-substituted quinoline compounds as intermediates in the manufacture of receptor tyrosine kinase inhibitors and intermediate compounds used in the methods thereof, wherein the 4-substituted quinoline compound has the following general formula (I): |
| 10/07/2008 | US7432283 Heterocyclic GABAA subtype selective receptor modulators |
| 10/07/2008 | US7432281 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist |
| 10/07/2008 | US7432268 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 10/07/2008 | CA2435946C Piperidine derivatives as neurokinin 1 antagonists |
| 10/07/2008 | CA2416685C Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 10/07/2008 | CA2248143C Process to prepare oxazolidinones |
| 10/02/2008 | WO2008117861A1 Intraocular pressure lowering agents containing phenylenediamine derivatives as the active ingredient |
| 10/02/2008 | WO2008117796A1 Novel mutilin derivatives |
| 10/02/2008 | US20080242656 N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use Thereof |
| 10/01/2008 | EP1975243A1 A method of isolating stem cells |
| 10/01/2008 | EP1975153A2 Protease inhibitors |
| 10/01/2008 | EP1973880A1 Piperazinyl derivatives as modulators of chemokine receptor activity |
| 10/01/2008 | EP1663934A4 Alpha-hydroxy-benzeneacetic acid derivatives, and compounds having two 5-membered lactone rings fused to central cyclohexa-1,4-diene nucleus based upon the same, and uses of the compounds |
| 10/01/2008 | EP1372655B1 Cathepsin cysteine protease inhibitors |
| 10/01/2008 | CN101277925A Method for preparing aminodiglycol (ADG) and morpholine |
| 09/30/2008 | US7429677 3'-methylene-bis(6-((4-methylphenyl)sulfonylamino)-benzoic acid) , or its N-oxide form, salt, stereoisomeric form, racemic mixture, prodrug or ester; block HIV from entering the human cell by interfering with various phases of attachment and fusion between HIV and the cell; Anti HIV agent; AIDS |
| 09/30/2008 | US7429618 substituted triarylmethane compounds for immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists |
| 09/30/2008 | US7429603 C-fms kinase inhibitors |
| 09/30/2008 | US7429586 Non-imidazole aryloxyalkylamines |
| 09/30/2008 | CA2381001C Carbamate derivative and agricultural/horticultural fungicide |
| 09/30/2008 | CA2303848C Substituted anilides |
| 09/25/2008 | WO2008116145A2 Soluble epoxide hydrolase inhibitors |
| 09/25/2008 | WO2008115804A1 Novel ido inhibitors and methods of use thereof |
| 09/25/2008 | WO2008114275A2 Anthranilic acid derivatives as anticancer agents and process for the preparation thereof |
| 09/25/2008 | WO2008113756A2 Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors |
| 09/25/2008 | WO2008113359A2 1- [2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition |
| 09/25/2008 | WO2008092672A3 Piperazine derivatives in cosmetic preparations containing diols |
| 09/25/2008 | US20080234498 Dopamine transporters; therapy for attention deficit disorders; Alzheimer's disease; Parkinson's dosease; antidepressants |
| 09/25/2008 | US20080234320 Curcumin analogs with anti-tumor and anti-angiogenic properties |
| 09/25/2008 | US20080234282 Especially 1-(2-(naphthylmethoxy)-1-phenylethyl)piperazine derivatives: 4-{[2-(3,chloro-4-fluorophenyl)-2-piperazin-1-ylethoxy]methyl}-3-methoxy-2-naphthonitrile; neurokinin 1 antagonists; antidepressants |
| 09/25/2008 | US20080234281 2,3-Dihydrooxadiazoles such as 3-acetyl-5-(2,5-difluorophenyl)-2-phenyl-2,3-dihydro-1,3,4-oxadiazole and 3-[3-acetyl-5-(2,5-difluorophenyl)-2-phenyl-2,3-dihydro-1,3,4-oxadiazol-2-yl]-N,N-dimethylpropan-1-amine that are useful for treating cancer |
| 09/25/2008 | US20080234274 Novel Compounds |
| 09/25/2008 | US20080234272 Novel Piperazines as Antimalarial Agents |
| 09/25/2008 | US20080234271 Arylphenylamino- and Arylphenylether-Sulfide Derivatives, Useful For the Treatment of Inflammatory and Immune Diseases, and Pharmaceutical Compositions Containing Them |
| 09/25/2008 | US20080234254 anticarcinogenic agents for treating leukaemia, non-small cell lung cancers, colonic cancers, breast cancers, ovarian cancers, renal cancers and melanoma; in vivo hydrolysable ester or amide; N-(2-amino-phenyl)-4-[1-(3,4-dihydroisoquinolin-2(1H)-ylmethyl)vinyl]benzamide; solid phase synthesis |
| 09/25/2008 | CA2680239A1 Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors |
| 09/24/2008 | EP1972617A1 Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors |
| 09/24/2008 | EP1972615A1 Cycloalkanecarboxamide derivative and method for producing same |
| 09/24/2008 | EP1971585A1 Process for the preparation of a pharmaceutical intermediate |
| 09/24/2008 | EP1408986B1 Proteomimetic compounds and methods |
| 09/24/2008 | CN101273024A Novel benzo[D][1,3]-dioxol derivatives |
| 09/24/2008 | CN100420945C Method and device for detecting and insolating pharmacological compounds being contained in substance mixtures |
| 09/24/2008 | CN100420379C Stable ethene in hibitory compound and its prepn method |
| 09/23/2008 | US7427632 Factor Xa inhibitors |
| 09/23/2008 | US7427612 Such as 1-(4-{4-[2-(cyclopropylmethyl-amino)-5-nitro-benzoyl]-piperazin-1-yl}-3-fluoro- phenyl)-ethanone for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease |
| 09/23/2008 | US7427394 Delivering labile agents; buffering effect; transfecting nucleic acids; nontoxic |
| 09/23/2008 | CA2379747C Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 09/23/2008 | CA2378382C Carboxylic acid amides, pharmaceutical compositions containing these compounds, the use and preparation thereof |
| 09/23/2008 | CA2310055C New urethanes, the thio and dithio analogues thereof,the salts thereof, pharmaceutical compositions containing these compounds and their use as well as process for preparing them |
| 09/23/2008 | CA2283643C Certain cyclic thio substituted acylaminoacid amide derivatives |
| 09/23/2008 | CA2198238C Piperidine derivatives as neurokinin antagonists |
| 09/18/2008 | WO2008112440A1 Piperazine and piperidine mglur5 potentiators |
| 09/18/2008 | WO2008110698A2 Method for preparing fluorinated sulphanylamides and sulphinamidines and uses thereof |
| 09/18/2008 | WO2008110586A2 New process for the preparation of levocetirizine and intermediates thereof |
| 09/18/2008 | US20080227814 Ethanolamine derivatives such as 6-hydroxy-1-(p-(2-(1-pyrrolidinyl)ethoxy)phenyl)-2-(p-methylsulfonylphenyl)tetralin and 6-hydroxy-2-(p-(trifluoromethyl)phenyl)-3-(p-(2-(1-piperidinyl)ethoxy)benzoyl)benzothiophene; treating endometriosis and uterine leiomyoma. |
| 09/18/2008 | US20080227784 5-chloro-N-(3-fluoro-4-morpholinophenyl)-2-hydroxybenzamide; prophylactic and/or therapeutic treatment of diseases caused by an activation of STAT6 and/or NF- kappa B |
| 09/18/2008 | US20080227676 Amine reaction compounds comprising one or more active ingredient |
| 09/18/2008 | US20080226716 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal |
| 09/18/2008 | US20080226550 Mercaptan containing diagnostic agents for imaging malignant melanoma and distant metastases and rhenium (186Re, 188Re) therapeutic complexes for treating the same |
| 09/18/2008 | CA2677295A1 Method for preparing fluorinated sulphanylamides and sulphinamidines and uses thereof |
| 09/17/2008 | EP1968962A2 Diaza heterocyclic sulfonamide derivatives and their uses |
| 09/17/2008 | EP1968961A2 Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation |
| 09/17/2008 | EP1968960A2 Racemic separation of 2,6-trans-dimethylmorpholine |
| 09/17/2008 | EP1824827B1 Method for producing onium salts comprising alkyl anions or aryl sulfonate anions or alkyl anions or aryl carboxylate anions having a low halide content |
| 09/17/2008 | EP1409477B1 Piperidine derivatives as nmda receptor antagonists |
| 09/17/2008 | EP1392639B1 Pyruvate derivatives |
| 09/17/2008 | CN101268061A Process to prepare amino acid derivatives |
| 09/17/2008 | CN101268041A Sulphonamide derivatives |
| 09/17/2008 | CN101265262A New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 09/16/2008 | US7425642 Anti-diabetic activity, improves insulin resistance and control the blood glucose level more safely, simulates activity of peroxisome proliferator-activated receptor; (1-{(2E)-3-[3-(Bromomethyl)phenyl]prop-2-en-1-yl}-1H-pyrrol-2-yl)(4-methyl-phenyl)methanone |
| 09/16/2008 | US7425641 Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions |
| 09/16/2008 | US7425631 Compounds and methods of use |
| 09/16/2008 | US7425554 1,2-di(cyclic)substituted benzene compounds |
| 09/16/2008 | CA2515338C Inhibitors of histone deacetylase |
| 09/12/2008 | WO2008109175A1 Deuterated piperazine derivatives as anti-anginal compounds |
| 09/12/2008 | WO2008107879A1 Novel cannabidiol derivatives and their use as anti-inflammatory agents |
| 09/12/2008 | WO2008107176A1 Meta-substituted phenyl sulfonyl amides of secondary amino acid amides, the production thereof, and use thereof as matriptase inhibitors |
| 09/12/2008 | WO2007113309A3 Compounds which inhibit the glycine transporter and uses thereof |
| 09/11/2008 | US20080221206 less anesthetic activity, but with more anti-inflammatory and spasmolytic activity; asthma, rhinitis, allergic urticaria, chronic lung inflammation associated with eosinophilia, following the example of atopic asthma and chronic intestinal inflammation, as colitis for instance |
| 09/11/2008 | US20080221106 Arylamine Ketones, Their Preparation Methods, The Pharmaceutical Composition Containing Them And Their Use |
| 09/11/2008 | US20080221096 Pyrido[3' ,2':4,5]Furo[3,2-d]Pyrimidine Derivatives |
| 09/11/2008 | US20080220454 Using erastin as therapeutic agent in treatment of cell proliferative disorders associated with mutation in ras gene |
| 09/11/2008 | US20080217580 Organic Luminescent Element |
| 09/10/2008 | EP1966186A1 Process for the preparation of imatinib |
| 09/10/2008 | EP1966180A1 Photochromic indeno-fused naphthopyrans |
| 09/10/2008 | EP1966142A2 New phenanthridine derivatives as bradykinin antagonists |
| 09/10/2008 | EP1966132A2 Compounds which modulate the cb2 receptor |
| 09/10/2008 | CN101260092A Method for preparing cinepazide maleate |
| 09/10/2008 | CN100417641C Arylcycloalkyl derivatives having branched side chains used as ppar receptor regulator, processes for their preparation and their use as pharmaceuticals |
| 09/09/2008 | US7423181 Aminoalkoxy-functional chalcones |
| 09/09/2008 | US7423176 Bicyclic aromatic sulfinyl derivatives |
| 09/09/2008 | US7423175 Vanilloid receptor (VR1) antagonists; side effects reduction, oral availability; To treat urinary incontinence, urge urinary incontinence, overactive bladder, pain, and/or inflammatory diseases such as asthma and COPD; N-[2-(2-Fluorophenoxy)ethyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)-urea |